238 related articles for article (PubMed ID: 25675651)
1. Patient profile and treatment satisfaction of Brazilian leprosy patients in a clinical trial of uniform six-month multidrug therapy (U-MDT/CT-BR).
Ferreira IP; Buhrer-Sékula S; De Oliveira MR; Gonçalves Hde S; Pontes MA; Penna ML; Cruz R; Penna GO
Lepr Rev; 2014 Dec; 85(4):267-74. PubMed ID: 25675651
[TBL] [Abstract][Full Text] [Related]
2.
Hungria EM; Bührer-Sékula S; Oliveira RM; Aderaldo LC; Pontes MAA; Cruz R; de Gonçalves HS; Penna MLF; Penna GO; Stefani MMA
Front Immunol; 2018; 9():915. PubMed ID: 29867930
[TBL] [Abstract][Full Text] [Related]
3. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.
Penna GO; Bührer-Sékula S; Kerr LRS; Stefani MMA; Rodrigues LC; de Araújo MG; Ramos AMC; de Andrade ARC; Costa MB; Rosa PS; Gonçalves HS; Cruz R; Barreto ML; Pontes MAA; Penna MLF
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005725. PubMed ID: 28704363
[TBL] [Abstract][Full Text] [Related]
4. Late relapses in leprosy patients in Brazil: 10-year post-trial of uniform multidrug therapy (U-MDT/CT-BR).
Penna GO; Pontes MAA; Talhari S; Gonçalves HS; Talhari C; Pessoa AS; Pedroza V; Bührer-Sékula S; Stefani MMA; Penna MLF
Braz J Infect Dis; 2024; 28(2):103745. PubMed ID: 38697216
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach.
Cruz RCDS; Bührer-Sékula S; Penna GO; Moraes MEA; Gonçalves HS; Stefani MMA; Penna MLF; Pontes MAA; Talhari S
An Bras Dermatol; 2018 Jun; 93(3):377-384. PubMed ID: 29924240
[TBL] [Abstract][Full Text] [Related]
6. Description of leprosy classification at baseline among patients enrolled at the uniform multidrug therapy clinical trial for leprosy patients in Brazil.
Moura RS; Penna GO; Cardoso LP; de Andrade Pontes MA; Cruz R; de Sá Gonçalves H; Fernandes Penna ML; de Araújo Stefani MM; Bührer-Sékula S
Am J Trop Med Hyg; 2015 Jun; 92(6):1280-4. PubMed ID: 25940192
[TBL] [Abstract][Full Text] [Related]
7. Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil.
Hungria EM; Oliveira RM; Penna GO; Aderaldo LC; Pontes MA; Cruz R; Gonçalves HS; Penna ML; Kerr LR; Stefani MM; Bührer-Sékula S
Infect Dis Poverty; 2016 Dec; 5(1):110. PubMed ID: 27919284
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of uniform-MDT and WHO MDT in Pauci and Multi bacillary leprosy patients over 24 months of observation.
Rao PN; Suneetha S; Pratap DV
Lepr Rev; 2009 Jun; 80(2):143-55. PubMed ID: 19743618
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.
Kumar A; Girdhar A; Girdhar BK
Indian J Dermatol Venereol Leprol; 2015; 81(4):356-62. PubMed ID: 26144850
[TBL] [Abstract][Full Text] [Related]
10. Results from the clinical trial of uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): decrease in bacteriological index.
Penna ML; Bűhrer-Sékula S; Pontes MA; Cruz R; Gonçalves Hde S; Penna GO
Lepr Rev; 2014 Dec; 85(4):262-6. PubMed ID: 25675650
[TBL] [Abstract][Full Text] [Related]
11. OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil.
Cunha Mda G; Virmond M; Schettini AP; Cruz RC; Ura S; Ghuidella C; Viana Fdos R; Avelleira JC; Campos AA; Filho B
Lepr Rev; 2012 Sep; 83(3):261-8. PubMed ID: 23356027
[TBL] [Abstract][Full Text] [Related]
12. Primary results of clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): reactions frequency in multibacillary patients.
Penna ML; Buhrer-Sékula S; Pontes MA; Cruz R; Gonçalves Hde S; Penna GO
Lepr Rev; 2012 Sep; 83(3):308-19. PubMed ID: 23356032
[TBL] [Abstract][Full Text] [Related]
13. Physical disability and social participation in patients affected by leprosy after discontinuation of multidrug therapy.
de Castro LE; da Cunha AJ; Fontana AP; de Castro Halfoun VL; Gomes MK
Lepr Rev; 2014 Sep; 85(3):208-17. PubMed ID: 25509722
[TBL] [Abstract][Full Text] [Related]
14. International open trial of uniform multi-drug therapy regimen for 6 months for all types of leprosy patients: rationale, design and preliminary results.
Kroger A; Pannikar V; Htoon MT; Jamesh A; Katoch K; Krishnamurthy P; Ramalingam K; Jianping S; Jadhav V; Gupte MD; Manickam P
Trop Med Int Health; 2008 May; 13(5):594-602. PubMed ID: 18346026
[TBL] [Abstract][Full Text] [Related]
15. MDT-MB therapy in paucibacillary leprosy: a clinicopathological assessment.
Prasad PV; Babu A; Kaviarasan PK; Viswanathan P; Tippoo R
Indian J Dermatol Venereol Leprol; 2005; 71(4):242-5. PubMed ID: 16394431
[TBL] [Abstract][Full Text] [Related]
16. Incidence of neuritis among paucibacillary leprosy patients during treatment and surveillance.
John AS
Indian J Lepr; 2004; 76(3):215-22. PubMed ID: 15835606
[TBL] [Abstract][Full Text] [Related]
17. Preliminary assessment of multidrug therapy in leprosy patients in Western Samoa.
Paksoy N; Levi V
N Z Med J; 1989 Nov; 102(879):589-91. PubMed ID: 2812597
[TBL] [Abstract][Full Text] [Related]
18. [A trial of polychemotherapy of leprosy in the Dakar region. Initial observations on the acceptability of the protocols used].
Millan J; Bodian M; Naudin JC; Diouf B; Boucher P; Ndoye B; Grosset J
Acta Leprol; 1986; 4(1):19-35. PubMed ID: 3526792
[TBL] [Abstract][Full Text] [Related]
19. Studies on risk of leprosy relapses in China: relapses after treatment with multidrug therapy.
Chen XS; Li WZ; Jiang C; Ye GY
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):379-87. PubMed ID: 10700911
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
